Osteoarthritis Pain
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
M&
Merck & Co.RAHWAY, NJ
1 program1
Comparator: Iontophoresis and Laser Doppler with ATPPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Acadia PharmaceuticalsACP-044 Dose A
Merck & Co.Comparator: Iontophoresis and Laser Doppler with ATP
Clinical Trials (2)
Total enrollment: 105 patients across 2 trials
Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee
Start: Jul 2021Est. completion: Nov 202261 patients
Phase 2Terminated
Study to Evaluate ATP-induced Pain and ATP-induced Dermal Vasodilation by Iontophoresis (0000-118)(COMPLETED)
Start: Oct 2009Est. completion: Jun 201144 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space